In contrast, CD4+ T cells recognise tumour antigens bound to MHC class II molecules on antigen presenting cells and help to initiate tumour‐specific cytotoxic T lymphocyte (CTL) responses (Tay et al. 2021). This evidence concerns the gene CD4 and neoplasm.